Free Trial
LON:EAH

ECO Animal Health Group 11/28/2024 Earnings Report

ECO Animal Health Group logo
GBX 80.60 +6.60 (+8.92%)
As of 07/18/2025 11:38 AM Eastern

ECO Animal Health Group EPS Results

Actual EPS
-GBX 2.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ECO Animal Health Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ECO Animal Health Group Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

ECO Animal Health Group Earnings Headlines

Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.
ECO Animal Health Group (LON:EAH) Stock Price Up 8% - Here's Why
See More ECO Animal Health Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ECO Animal Health Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ECO Animal Health Group and other key companies, straight to your email.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

View ECO Animal Health Group Profile

More Earnings Resources from MarketBeat